NCT07341737 2026-01-15SL-28 for Advanced Solid TumoursSecond Life TherapeuticsPhase 1/2 Not yet recruiting60 enrolled
NCT06078670 2023-10-12PARP Inhibitor CVL218 in Combination Therapy for Patients With Advanced Solid TumorsFujian Cancer HospitalPhase 1/2 Not yet recruiting96 enrolled